Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy

Blood Adv (2019) 3 (22): 3539–3549.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals